Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Those who took offering so far lost another 50% on top

<< Previous

Bullboard Posts

Next >>

Comment by GunnerGon Nov 21, 2019 5:37pm

65 Views

Post# 30380106

RE:RE:Those who took offering so far lost another 50% on top

Another newbie to stockhouse with some great insight.

If you sold you rights at a profit; you'd have made up some of your losses.

very insightful to some. LOL

AllonGreen wrote:
Not if you exercised your rights, sold at $22 back down to your initial share count ;)

Then you'd have caught up on at least some of your losses......

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing